-
STAT+: Cigarette, vape maker Reynolds American calls on the FDA to pull Puff Bar, Elf Bar, and other disposables off store shelves
STAT+: Cigarette, vape maker Reynolds American calls on the FDA to pull Puff Bar, Elf Bar, and other disposables off store shelves WASHINGTON — Cigarette giant Reynolds American is calling on the Food and Drug Administration to crack down on manufacturers of disposable e-cigarettes, like Puff Bar and Elf Bar, which are increasingly being used…
-
A Health-Heavy State of the Union
A Health-Heavy State of the Union The Host Julie Rovner KHN @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KHN’s weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy…
-
Gilead Sciences Drug Wins FDA Approval in Most Common Type of Breast Cancer
Gilead Sciences Drug Wins FDA Approval in Most Common Type of Breast Cancer Gilead Sciences drug Trodelvy is now approved for treating patients whose breast cancer is classified as HR positive and HER2 negative, expanding use of the drug to a much wider group of patients. In other regulatory approval news, use of Takeda Pharmaceutical’s…
-
Opinion: FDA: Base blood donation policy on science, not stigma
Opinion: FDA: Base blood donation policy on science, not stigma As a doctor, I have dedicated my life to saving the lives of others. But as a gay doctor, I have long been unable to do one simple thing that saves lives: donate blood. For more than 30 years, policies in the United States have…
-
Opinion: The FDA is the right agency to regulate CBD products, but it needs help
Opinion: The FDA is the right agency to regulate CBD products, but it needs help The dietary supplement industry has been begging for federal oversight of products containing cannabidiol (CBD), a non-psychoactive compound found in the cannabis plant that is being incorporated into a bewildering range of oils, tinctures, edibles, and other products. Certification by…
-
GSK Gets FDA Nod for Drug Treating Anemia From Chronic Kidney Disease
GSK Gets FDA Nod for Drug Treating Anemia From Chronic Kidney Disease The FDA approved GSK drug Jesduvroq for treating anemia in patients with chronic kidney disease. The once-daily pill is the first oral medicine to pass FDA muster in this indication, giving patients a more convenient alternative to injectable anemia therapies. Information Courtesy By:…
-
Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy
Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals. Information Courtesy By: Frank…
Got any book recommendations?